Loading...
OTCMNRXCF
Market cap0kUSD
Aug 15, Last price  
0.00USD
Name

NeutriSci International Inc

Chart & Performance

D1W1MN
OTCM:NRXCF chart
P/E
—
P/S
0.00
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
24.82%
Revenues
458k
+465.86%
2,3861,993101,43861,995390,068630,458311,415488,172218,482274,800000125,351151,07282,66396,53874,57280,894457,750
Net income
-771k
L-50.98%
-200,259-1,009,216-2,772,305-1,983,111-1,807,329-3,042,328-2,062,903-1,758,214-2,145,647-2,493,0617,905,504-389,0780-2,564,830-2,122,269-2,382,899-1,612,868-1,952,547-1,572,197-770,694
CFO
-166k
L-84.04%
-174,619-875,871-1,719,142-1,519,341-1,999,876-2,991,108-1,754,890-1,180,267-1,263,640-1,306,618-1,154,666-291,4890-2,256,554-1,514,892-2,045,426-1,240,916-1,521,223-1,040,825-166,090

Profile

NeutriSci International Inc. develops, markets, and distributes nutraceutical products in Canada, the United States, Europe, Asia, and South America. It offers neuenergy, an energy tablet designed to deliver enhanced focus and mental clarity. The company sells its products through a distribution network of retail and online channels. NeutriSci International Inc. has partnership with LaSanta Botanicals, Nutritional High, and Naturally Splendid. NeutriSci International Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
URL
https://neutrisci.com/
IPO date
Jul 09, 2001
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
458
465.86%
81
8.48%
Cost of revenue
1,097
1,424
Unusual Expense (Income)
NOPBT
(640)
(1,343)
NOPBT Margin
Operating Taxes
26
Tax Rate
NOPAT
(640)
(1,369)
Net income
(771)
-50.98%
(1,572)
-19.48%
Dividends
Dividend yield
Proceeds from repurchase of equity
197
402
BB yield
-7.90%
-4.60%
Debt
Debt current
119
(440)
Long-term debt
60
60
Deferred revenue
Other long-term liabilities
Net debt
3
(411)
Cash flow
Cash from operating activities
(166)
(1,041)
CAPEX
(5)
(107)
Cash from investing activities
(5)
(107)
Cash from financing activities
315
1,172
FCF
(629)
(1,555)
Balance
Cash
175
31
Long term investments
Excess cash
152
27
Stockholders' equity
(5,197)
(4,574)
Invested Capital
4,759
4,146
ROIC
ROCE
145.93%
314.25%
EV
Common stock shares outstanding
166,151
158,585
Price
0.02
-72.73%
0.06
-57.69%
Market cap
2,492
-71.43%
8,722
-53.21%
EV
2,496
8,312
EBITDA
(602)
(1,298)
EV/EBITDA
Interest
1,000
Interest/NOPBT